Kodiak Sciences (KOD) Competitors $9.95 +2.12 (+27.08%) (As of 10:39 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends KOD vs. PRAX, ARQT, RCUS, SYRE, SNDX, DAWN, MESO, SPRY, ARDX, and RCKTShould you be buying Kodiak Sciences stock or one of its competitors? The main competitors of Kodiak Sciences include Praxis Precision Medicines (PRAX), Arcutis Biotherapeutics (ARQT), Arcus Biosciences (RCUS), Spyre Therapeutics (SYRE), Syndax Pharmaceuticals (SNDX), Day One Biopharmaceuticals (DAWN), Mesoblast (MESO), ARS Pharmaceuticals (SPRY), Ardelyx (ARDX), and Rocket Pharmaceuticals (RCKT). These companies are all part of the "pharmaceutical products" industry. Kodiak Sciences vs. Praxis Precision Medicines Arcutis Biotherapeutics Arcus Biosciences Spyre Therapeutics Syndax Pharmaceuticals Day One Biopharmaceuticals Mesoblast ARS Pharmaceuticals Ardelyx Rocket Pharmaceuticals Kodiak Sciences (NASDAQ:KOD) and Praxis Precision Medicines (NASDAQ:PRAX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, community ranking, earnings, analyst recommendations, valuation, risk, media sentiment and dividends. Does the media refer more to KOD or PRAX? In the previous week, Praxis Precision Medicines had 4 more articles in the media than Kodiak Sciences. MarketBeat recorded 7 mentions for Praxis Precision Medicines and 3 mentions for Kodiak Sciences. Praxis Precision Medicines' average media sentiment score of 1.28 beat Kodiak Sciences' score of 0.00 indicating that Praxis Precision Medicines is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kodiak Sciences 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Praxis Precision Medicines 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in KOD or PRAX? 89.1% of Kodiak Sciences shares are held by institutional investors. Comparatively, 67.8% of Praxis Precision Medicines shares are held by institutional investors. 45.3% of Kodiak Sciences shares are held by insiders. Comparatively, 2.7% of Praxis Precision Medicines shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has higher valuation and earnings, KOD or PRAX? Praxis Precision Medicines has higher revenue and earnings than Kodiak Sciences. Praxis Precision Medicines is trading at a lower price-to-earnings ratio than Kodiak Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKodiak SciencesN/AN/A-$260.49M-$3.65-2.73Praxis Precision Medicines$2.45M526.48-$123.28M-$10.30-6.72 Is KOD or PRAX more profitable? Kodiak Sciences has a net margin of 0.00% compared to Praxis Precision Medicines' net margin of -9,409.22%. Praxis Precision Medicines' return on equity of -54.86% beat Kodiak Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Kodiak SciencesN/A -84.52% -45.40% Praxis Precision Medicines -9,409.22%-54.86%-50.52% Which has more risk and volatility, KOD or PRAX? Kodiak Sciences has a beta of 2.38, suggesting that its share price is 138% more volatile than the S&P 500. Comparatively, Praxis Precision Medicines has a beta of 2.67, suggesting that its share price is 167% more volatile than the S&P 500. Do analysts recommend KOD or PRAX? Kodiak Sciences presently has a consensus target price of $6.80, indicating a potential downside of 31.66%. Praxis Precision Medicines has a consensus target price of $146.33, indicating a potential upside of 111.46%. Given Praxis Precision Medicines' stronger consensus rating and higher possible upside, analysts plainly believe Praxis Precision Medicines is more favorable than Kodiak Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kodiak Sciences 2 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.80Praxis Precision Medicines 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 Does the MarketBeat Community believe in KOD or PRAX? Praxis Precision Medicines received 22 more outperform votes than Kodiak Sciences when rated by MarketBeat users. Likewise, 71.93% of users gave Praxis Precision Medicines an outperform vote while only 27.54% of users gave Kodiak Sciences an outperform vote. CompanyUnderperformOutperformKodiak SciencesOutperform Votes1927.54% Underperform Votes5072.46% Praxis Precision MedicinesOutperform Votes4171.93% Underperform Votes1628.07% SummaryPraxis Precision Medicines beats Kodiak Sciences on 11 of the 17 factors compared between the two stocks. Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. Get Kodiak Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KOD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KOD vs. The Competition Export to ExcelMetricKodiak SciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$523.57M$3.03B$4.98B$9.16BDividend YieldN/A1.86%7.70%4.06%P/E Ratio-2.7315.3477.2913.39Price / SalesN/A378.791,377.39159.82Price / CashN/A171.1034.4035.60Price / Book1.964.004.825.00Net Income-$260.49M-$41.51M$114.44M$223.10M7 Day Performance33.92%3.38%6.65%3.84%1 Month Performance102.24%4.23%122.41%9.76%1 Year Performance214.87%37.46%157.30%31.90% Kodiak Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KODKodiak Sciences2.0951 of 5 stars$9.95+27.1%$6.80-31.7%+147.8%$523.57MN/A-2.7390Analyst UpgradeNews CoverageGap UpHigh Trading VolumePRAXPraxis Precision Medicines2.9417 of 5 stars$79.44-0.9%$146.33+84.2%+315.0%$1.48B$1.61M-7.78110Positive NewsARQTArcutis Biotherapeutics1.4865 of 5 stars$12.52-4.0%$15.50+23.8%+474.1%$1.47B$138.71M-7.28150RCUSArcus Biosciences3.0231 of 5 stars$15.71+1.7%$34.00+116.4%+9.7%$1.44B$117M-4.90500SYRESpyre Therapeutics2.2995 of 5 stars$27.64-2.8%$48.57+75.7%+38.1%$1.42B$890,000.00-3.81100SNDXSyndax Pharmaceuticals4.3154 of 5 stars$16.49-1.4%$37.64+128.2%+2.2%$1.41B$139.71M-4.61110DAWNDay One Biopharmaceuticals1.8211 of 5 stars$13.88-0.4%$35.71+157.3%+12.1%$1.40B$101.95M-13.3860MESOMesoblast0.6359 of 5 stars$12.01+2.7%$11.50-4.2%+444.1%$1.37B$5.90M0.0080Gap DownSPRYARS Pharmaceuticals2.3536 of 5 stars$13.65-5.9%$24.00+75.8%+163.5%$1.33B$30,000.00-26.7690Insider TradeAnalyst RevisionARDXArdelyx4.0385 of 5 stars$5.55-2.1%$10.42+87.7%+9.4%$1.31B$124.46M-18.90267Analyst RevisionRCKTRocket Pharmaceuticals4.8611 of 5 stars$14.37-0.1%$51.00+254.9%-44.9%$1.31BN/A-5.23240 Related Companies and Tools Related Companies PRAX Competitors ARQT Competitors RCUS Competitors SYRE Competitors SNDX Competitors DAWN Competitors MESO Competitors SPRY Competitors ARDX Competitors RCKT Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KOD) was last updated on 12/9/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kodiak Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kodiak Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KOD Stock Alerts